Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Roger

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Molecular Immunology|September 28, 2007
Immune recognition of botulinum neurotoxin B: antibody-binding regions on the heavy chain of the toxinBehzod Z Dolimbek, Lance E Steward, K Roger Aoki, et al.
Immunology Letters|November 30, 2011
Antibodies against a synthetic peptide designed to mimic a surface area of the H chain of botulinum neurotoxin AM Zouhair Atassi, Behzod Z Dolimbek, Lance E Steward, et al.
Critical Reviews in Immunology|January 17, 2008
Molecular bases of protective immune responses against botulinum neurotoxin A--how antitoxin antibodies block its actionM Zouhair Atassi, Behzod Z Dolimbek, Lance E Steward, et al.
The Protein Journal|June 24, 2010
Inhibition of botulinum neurotoxin a toxic action in vivo by synthetic synaptosome- and blocking antibody-binding regionsM Zouhair Atassi, Behzod Z Dolimbek, Lance E Steward, et al.
Immunobiology|December 25, 2015
Submolecular recognition of the C-terminal domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patientsMinako Oshima, Philip Deitiker, Joseph Jankovic, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 18, 2004
Is the light chain subcellular localization an important factor in botulinum toxin duration of action?Ester Fernández-Salas, Helen Ho, Patton Garay, et al.
Journal of Molecular Recognition : JMR|September 19, 2006
A peptide-based immunoassay for antibodies against botulinum neurotoxin AM Zouhair Atassi, Behzod Z Dolimbek, Philip Deitiker, et al.
The Protein Journal|April 18, 2014
Synaptotagmin II and gangliosides bind independently with botulinum neurotoxin B but each restrains the otherM Zouhair Atassi, Midori Taruishi, Masooma Naqvi, et al.
Preventive Medicine Reports|February 5, 2016
Health behaviors of mandated and voluntary students in a motivational intervention programDonna M Kazemi, Maureen J Levine, Jacek Dmochowski, et al.
Immunobiology|October 4, 2011
Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B moleculeM Zouhair Atassi, Joseph Jankovic, Lance E Steward, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Molecular Immunology|September 28, 2007
Immune recognition of botulinum neurotoxin B: antibody-binding regions on the heavy chain of the toxinBehzod Z Dolimbek, Lance E Steward, K Roger Aoki, et al.
Immunology Letters|November 30, 2011
Antibodies against a synthetic peptide designed to mimic a surface area of the H chain of botulinum neurotoxin AM Zouhair Atassi, Behzod Z Dolimbek, Lance E Steward, et al.
Critical Reviews in Immunology|January 17, 2008
Molecular bases of protective immune responses against botulinum neurotoxin A--how antitoxin antibodies block its actionM Zouhair Atassi, Behzod Z Dolimbek, Lance E Steward, et al.
The Protein Journal|June 24, 2010
Inhibition of botulinum neurotoxin a toxic action in vivo by synthetic synaptosome- and blocking antibody-binding regionsM Zouhair Atassi, Behzod Z Dolimbek, Lance E Steward, et al.
Immunobiology|December 25, 2015
Submolecular recognition of the C-terminal domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patientsMinako Oshima, Philip Deitiker, Joseph Jankovic, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 18, 2004
Is the light chain subcellular localization an important factor in botulinum toxin duration of action?Ester Fernández-Salas, Helen Ho, Patton Garay, et al.
Journal of Molecular Recognition : JMR|September 19, 2006
A peptide-based immunoassay for antibodies against botulinum neurotoxin AM Zouhair Atassi, Behzod Z Dolimbek, Philip Deitiker, et al.
The Protein Journal|April 18, 2014
Synaptotagmin II and gangliosides bind independently with botulinum neurotoxin B but each restrains the otherM Zouhair Atassi, Midori Taruishi, Masooma Naqvi, et al.
Preventive Medicine Reports|February 5, 2016
Health behaviors of mandated and voluntary students in a motivational intervention programDonna M Kazemi, Maureen J Levine, Jacek Dmochowski, et al.
Immunobiology|October 4, 2011
Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B moleculeM Zouhair Atassi, Joseph Jankovic, Lance E Steward, et al.
Pageof 8